39431016|t|A novel ferroptosis inhibitor, Thonningianin A, improves Alzheimer's disease by activating GPX4.
39431016|a|Background: Ferroptosis, a recently unveiled iron-dependent form of cellular demise, has emerged as a pivotal process contributing to the pathology of Alzheimer's Disease (AD). Glutathione Peroxidase 4 (GPX4), a vital defense mechanism countering ferroptosis by nullifying lipid peroxides and maintaining cellular redox equilibrium, has garnered significant attention in AD. Thus, identifying ferroptosis inhibitors to target GPX4 activation may help mitigate neuronal damage and impede AD progression. Objectives: We aimed to screen potent ferroptosis inhibitors and investigate their mechanism of action and therapeutic potential in AD, as well as lay the groundwork for future research in this promising area of study. Methods: This study employed a natural compound library to screen potential ferroptosis inhibitors in RAS-selective lethal compounds 3 (RSL-3)-induced PC-12 cells. Ferroptosis was evaluated by examining the mitochondrial morphology and function, reactive oxygen species (ROS) production, and lipid peroxide levels. The ability to chelate iron and intracellular iron levels was determined by UHPLC-Q/TOF-MS/MS and PGSK staining, respectively. APP Swe/ind- or Tau P301L-overexpressing PC-12 cells, and Amyloid-beta transgenic CL4176 and Tau transgenic BR5270 Caenorhabditis elegans were employed as cellular and animal models of AD. Results: Thonningianin A (ThA) was identified as a novel ferroptosis inhibitor, as demonstrated by augmented cellular viability, mitigated mitochondrial impairment, diminished lipid peroxides, iron levels, and ROS generation. Mechanistically, ThA binds with GPX4 and enhances the AMPK/Nrf2 signaling pathway to stimulate GPX4 activation, effectively inhibiting ferroptosis. Moreover, in cellular and Caenorhabditis elegans AD models, ThA substantially inhibits ferroptosis by reducing ROS, lipid peroxide generation, and iron accumulation. Furthermore, ThA significantly delays paralysis, ameliorates food-sensing deficits and increases worms' antioxidative capacity. Conclusion: ThA ameliorates AD by inhibiting neuronal ferroptosis mediated by GPX4 activation through its binding with GPX4 and the upregulation of the AMPK/Nrf2/GPX4 pathway.
39431016	8	19	ferroptosis	Disease	
39431016	31	46	Thonningianin A	Chemical	MESH:C411320
39431016	57	76	Alzheimer's disease	Disease	MESH:D000544
39431016	91	95	GPX4	Gene	29328
39431016	109	120	Ferroptosis	Disease	
39431016	142	146	iron	Chemical	MESH:D007501
39431016	248	267	Alzheimer's Disease	Disease	MESH:D000544
39431016	269	271	AD	Disease	MESH:D000544
39431016	274	298	Glutathione Peroxidase 4	Gene	29328
39431016	300	304	GPX4	Gene	29328
39431016	344	355	ferroptosis	Disease	
39431016	370	385	lipid peroxides	Chemical	MESH:D008054
39431016	468	470	AD	Disease	MESH:D000544
39431016	490	501	ferroptosis	Disease	
39431016	523	527	GPX4	Gene	29328
39431016	557	572	neuronal damage	Disease	MESH:D009410
39431016	584	586	AD	Disease	MESH:D000544
39431016	638	649	ferroptosis	Disease	
39431016	732	734	AD	Disease	MESH:D000544
39431016	895	906	ferroptosis	Disease	
39431016	935	953	lethal compounds 3	Chemical	-
39431016	955	960	RSL-3	Chemical	-
39431016	970	975	PC-12	CellLine	CVCL:0481
39431016	983	994	Ferroptosis	Disease	
39431016	1065	1088	reactive oxygen species	Chemical	MESH:D017382
39431016	1090	1093	ROS	Chemical	MESH:D017382
39431016	1111	1125	lipid peroxide	Chemical	MESH:D008054
39431016	1157	1161	iron	Chemical	MESH:D007501
39431016	1180	1184	iron	Chemical	MESH:D007501
39431016	1281	1286	P301L	ProteinMutation	tmVar:p|SUB|P|301|L;HGVS:p.P301L;VariantGroup:0;OriginalGene:29328;CorrespondingGene:2879;CorrespondingSpecies:10116
39431016	1302	1307	PC-12	CellLine	CVCL:0481
39431016	1343	1349	CL4176	CellLine	CVCL:3872
39431016	1369	1375	BR5270	CellLine	CVCL:4Y67
39431016	1376	1398	Caenorhabditis elegans	Species	6239
39431016	1446	1448	AD	Disease	MESH:D000544
39431016	1459	1474	Thonningianin A	Chemical	MESH:C411320
39431016	1476	1479	ThA	Chemical	MESH:C411320
39431016	1507	1518	ferroptosis	Disease	
39431016	1589	1613	mitochondrial impairment	Disease	MESH:D028361
39431016	1626	1641	lipid peroxides	Chemical	MESH:D008054
39431016	1643	1647	iron	Chemical	MESH:D007501
39431016	1660	1663	ROS	Chemical	MESH:D017382
39431016	1693	1696	ThA	Chemical	MESH:C411320
39431016	1708	1712	GPX4	Gene	29328
39431016	1730	1734	AMPK	Gene	78975
39431016	1735	1739	Nrf2	Gene	83619
39431016	1771	1775	GPX4	Gene	29328
39431016	1811	1822	ferroptosis	Disease	
39431016	1850	1872	Caenorhabditis elegans	Species	6239
39431016	1873	1875	AD	Disease	MESH:D000544
39431016	1884	1887	ThA	Chemical	MESH:C411320
39431016	1911	1922	ferroptosis	Disease	
39431016	1935	1938	ROS	Chemical	MESH:D017382
39431016	1940	1954	lipid peroxide	Chemical	MESH:D008054
39431016	1971	1975	iron	Chemical	MESH:D007501
39431016	2003	2006	ThA	Chemical	MESH:C411320
39431016	2028	2037	paralysis	Disease	MESH:D010243
39431016	2130	2133	ThA	Chemical	MESH:C411320
39431016	2146	2148	AD	Disease	MESH:D000544
39431016	2172	2183	ferroptosis	Disease	
39431016	2196	2200	GPX4	Gene	29328
39431016	2237	2241	GPX4	Gene	29328
39431016	2270	2274	AMPK	Gene	78975
39431016	2275	2279	Nrf2	Gene	83619
39431016	2280	2284	GPX4	Gene	29328
39431016	Association	29328	78975
39431016	Negative_Correlation	MESH:D008054	29328
39431016	Association	MESH:D000544	29328
39431016	Negative_Correlation	MESH:C411320	MESH:D017382
39431016	Association	29328	83619
39431016	Positive_Correlation	MESH:C411320	83619
39431016	Association	MESH:D000544	HGVS:p.P301L;CorrespondingGene:2879
39431016	Positive_Correlation	MESH:C411320	78975
39431016	Association	MESH:D009410	29328
39431016	Negative_Correlation	MESH:C411320	MESH:D028361
39431016	Negative_Correlation	MESH:C411320	MESH:D010243
39431016	Positive_Correlation	MESH:C411320	29328
39431016	Negative_Correlation	MESH:C411320	MESH:D008054
39431016	Association	MESH:D007501	MESH:D000544
39431016	Negative_Correlation	MESH:C411320	MESH:D000544
39431016	Negative_Correlation	MESH:C411320	MESH:D007501
39431016	Association	MESH:D000544	2879

